Kolte-Patil Developers Limited
Kolte-Patil Developers Limited (KOLTEPATIL.NS) Stock Competitors & Peer Comparison
See (KOLTEPATIL.NS) competitors and their performances in Stock Market.
Peer Comparison Table: Real Estate - Development Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| KOLTEPATIL.NS | ₹377.10 | -2.85% | 33.4B | 64.35 | ₹5.86 | N/A |
| DLF.BO | ₹594.45 | +0.75% | 1.5T | 33.36 | ₹17.82 | +1.01% |
| DLF.NS | ₹593.90 | +0.70% | 1.5T | 33.35 | ₹17.81 | +1.01% |
| LODHA.NS | ₹923.65 | +2.21% | 922.6B | 26.98 | ₹34.23 | +0.46% |
| LODHA.BO | ₹923.15 | +2.16% | 922.1B | 26.94 | ₹34.27 | +0.46% |
| OBEROIRLTY.NS | ₹1,692.60 | -0.06% | 615.4B | 23.76 | ₹71.24 | +0.47% |
| OBEROIRLTY.BO | ₹1,691.30 | -0.18% | 615B | 23.85 | ₹70.91 | +0.47% |
| GODREJPROP.BO | ₹1,789.15 | +1.69% | 538.9B | 34.69 | ₹51.57 | N/A |
| GODREJPROP.NS | ₹1,788.60 | +1.61% | 538.7B | 29.08 | ₹61.50 | N/A |
| ANANTRAJ.NS | ₹508.30 | +0.89% | 182.9B | 32.11 | ₹15.83 | +0.14% |
Stock Comparison
KOLTEPATIL.NS vs DLF.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, DLF.BO has a market cap of 1.5T. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while DLF.BO trades at ₹594.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas DLF.BO's P/E ratio is 33.36. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to DLF.BO's ROE of +0.10%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to DLF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check DLF.BO's competition here
KOLTEPATIL.NS vs DLF.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, DLF.NS has a market cap of 1.5T. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while DLF.NS trades at ₹593.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas DLF.NS's P/E ratio is 33.35. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to DLF.NS's ROE of +0.10%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to DLF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check DLF.NS's competition here
KOLTEPATIL.NS vs LODHA.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, LODHA.NS has a market cap of 922.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while LODHA.NS trades at ₹923.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas LODHA.NS's P/E ratio is 26.98. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to LODHA.NS's ROE of +0.16%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to LODHA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check LODHA.NS's competition here
KOLTEPATIL.NS vs LODHA.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, LODHA.BO has a market cap of 922.1B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while LODHA.BO trades at ₹923.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas LODHA.BO's P/E ratio is 26.94. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to LODHA.BO's ROE of +0.16%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to LODHA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check LODHA.BO's competition here
KOLTEPATIL.NS vs OBEROIRLTY.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, OBEROIRLTY.NS has a market cap of 615.4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while OBEROIRLTY.NS trades at ₹1,692.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas OBEROIRLTY.NS's P/E ratio is 23.76. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to OBEROIRLTY.NS's ROE of +0.15%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to OBEROIRLTY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check OBEROIRLTY.NS's competition here
KOLTEPATIL.NS vs OBEROIRLTY.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, OBEROIRLTY.BO has a market cap of 615B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while OBEROIRLTY.BO trades at ₹1,691.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas OBEROIRLTY.BO's P/E ratio is 23.85. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to OBEROIRLTY.BO's ROE of +0.15%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to OBEROIRLTY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check OBEROIRLTY.BO's competition here
KOLTEPATIL.NS vs GODREJPROP.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, GODREJPROP.BO has a market cap of 538.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while GODREJPROP.BO trades at ₹1,789.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas GODREJPROP.BO's P/E ratio is 34.69. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to GODREJPROP.BO's ROE of +0.10%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to GODREJPROP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check GODREJPROP.BO's competition here
KOLTEPATIL.NS vs GODREJPROP.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, GODREJPROP.NS has a market cap of 538.7B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while GODREJPROP.NS trades at ₹1,788.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas GODREJPROP.NS's P/E ratio is 29.08. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to GODREJPROP.NS's ROE of +0.10%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to GODREJPROP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check GODREJPROP.NS's competition here
KOLTEPATIL.NS vs ANANTRAJ.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ANANTRAJ.NS has a market cap of 182.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ANANTRAJ.NS trades at ₹508.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ANANTRAJ.NS's P/E ratio is 32.11. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ANANTRAJ.NS's ROE of +0.12%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to ANANTRAJ.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ANANTRAJ.NS's competition here
KOLTEPATIL.NS vs ANANTRAJ.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ANANTRAJ.BO has a market cap of 182.8B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ANANTRAJ.BO trades at ₹508.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ANANTRAJ.BO's P/E ratio is 33.40. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ANANTRAJ.BO's ROE of +0.12%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to ANANTRAJ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ANANTRAJ.BO's competition here
KOLTEPATIL.NS vs BRIGADE.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, BRIGADE.BO has a market cap of 161.4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while BRIGADE.BO trades at ₹659.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas BRIGADE.BO's P/E ratio is 2443.89. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to BRIGADE.BO's ROE of +0.10%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to BRIGADE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check BRIGADE.BO's competition here
KOLTEPATIL.NS vs BRIGADE.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, BRIGADE.NS has a market cap of 161.4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while BRIGADE.NS trades at ₹659.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas BRIGADE.NS's P/E ratio is 2443.52. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to BRIGADE.NS's ROE of +0.10%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to BRIGADE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check BRIGADE.NS's competition here
KOLTEPATIL.NS vs SOBHA.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SOBHA.BO has a market cap of 149.8B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SOBHA.BO trades at ₹1,400.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SOBHA.BO's P/E ratio is 104.54. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SOBHA.BO's ROE of +0.04%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to SOBHA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SOBHA.BO's competition here
KOLTEPATIL.NS vs SOBHA.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SOBHA.NS has a market cap of 149.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SOBHA.NS trades at ₹1,395.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SOBHA.NS's P/E ratio is 104.57. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SOBHA.NS's ROE of +0.04%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to SOBHA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SOBHA.NS's competition here
KOLTEPATIL.NS vs SIGNATURE.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SIGNATURE.BO has a market cap of 112.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SIGNATURE.BO trades at ₹803.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SIGNATURE.BO's P/E ratio is 10.33. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SIGNATURE.BO's ROE of +1.09%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to SIGNATURE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SIGNATURE.BO's competition here
KOLTEPATIL.NS vs SIGNATURE.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SIGNATURE.NS has a market cap of 112.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SIGNATURE.NS trades at ₹801.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SIGNATURE.NS's P/E ratio is 10.29. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SIGNATURE.NS's ROE of +1.09%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to SIGNATURE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SIGNATURE.NS's competition here
KOLTEPATIL.NS vs IBREALEST.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, IBREALEST.BO has a market cap of 95.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while IBREALEST.BO trades at ₹150.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas IBREALEST.BO's P/E ratio is -7.83. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to IBREALEST.BO's ROE of -0.32%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to IBREALEST.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check IBREALEST.BO's competition here
KOLTEPATIL.NS vs IBREALEST.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, IBREALEST.NS has a market cap of 83.4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while IBREALEST.NS trades at ₹131.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas IBREALEST.NS's P/E ratio is -6.85. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to IBREALEST.NS's ROE of +0.00%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to IBREALEST.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check IBREALEST.NS's competition here
KOLTEPATIL.NS vs MAXESTATES.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, MAXESTATES.BO has a market cap of 74.1B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while MAXESTATES.BO trades at ₹453.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas MAXESTATES.BO's P/E ratio is 458.13. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to MAXESTATES.BO's ROE of +0.01%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to MAXESTATES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check MAXESTATES.BO's competition here
KOLTEPATIL.NS vs MAXESTATES.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, MAXESTATES.NS has a market cap of 74.1B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while MAXESTATES.NS trades at ₹453.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas MAXESTATES.NS's P/E ratio is 457.98. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to MAXESTATES.NS's ROE of +0.01%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to MAXESTATES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check MAXESTATES.NS's competition here
KOLTEPATIL.NS vs MAHLIFE.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, MAHLIFE.NS has a market cap of 73B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while MAHLIFE.NS trades at ₹342.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas MAHLIFE.NS's P/E ratio is 23.45. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to MAHLIFE.NS's ROE of +0.10%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to MAHLIFE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check MAHLIFE.NS's competition here
KOLTEPATIL.NS vs MAHLIFE.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, MAHLIFE.BO has a market cap of 73B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while MAHLIFE.BO trades at ₹341.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas MAHLIFE.BO's P/E ratio is 23.41. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to MAHLIFE.BO's ROE of +0.10%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to MAHLIFE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check MAHLIFE.BO's competition here
KOLTEPATIL.NS vs KALPATARU.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, KALPATARU.NS has a market cap of 68.8B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while KALPATARU.NS trades at ₹334.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas KALPATARU.NS's P/E ratio is 70.20. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to KALPATARU.NS's ROE of +0.03%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to KALPATARU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check KALPATARU.NS's competition here
KOLTEPATIL.NS vs DBREALTY.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, DBREALTY.NS has a market cap of 65.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while DBREALTY.NS trades at ₹120.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas DBREALTY.NS's P/E ratio is 62.00. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to DBREALTY.NS's ROE of +0.02%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to DBREALTY.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check DBREALTY.NS's competition here
KOLTEPATIL.NS vs DBREALTY.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, DBREALTY.BO has a market cap of 64.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while DBREALTY.BO trades at ₹119.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas DBREALTY.BO's P/E ratio is 61.70. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to DBREALTY.BO's ROE of +0.02%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to DBREALTY.BO. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check DBREALTY.BO's competition here
KOLTEPATIL.NS vs GANESHHOU.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, GANESHHOU.NS has a market cap of 58.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while GANESHHOU.NS trades at ₹703.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas GANESHHOU.NS's P/E ratio is 13.97. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to GANESHHOU.NS's ROE of +0.25%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to GANESHHOU.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check GANESHHOU.NS's competition here
KOLTEPATIL.NS vs GANESHHOUC.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, GANESHHOUC.BO has a market cap of 58.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while GANESHHOUC.BO trades at ₹702.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas GANESHHOUC.BO's P/E ratio is 10.16. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to GANESHHOUC.BO's ROE of +0.22%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to GANESHHOUC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check GANESHHOUC.BO's competition here
KOLTEPATIL.NS vs GANESHHOU.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, GANESHHOU.BO has a market cap of 58.5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while GANESHHOU.BO trades at ₹701.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas GANESHHOU.BO's P/E ratio is 13.95. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to GANESHHOU.BO's ROE of +0.25%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to GANESHHOU.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check GANESHHOU.BO's competition here
KOLTEPATIL.NS vs NIRLON.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, NIRLON.BO has a market cap of 55.5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while NIRLON.BO trades at ₹616.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas NIRLON.BO's P/E ratio is 16.06. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to NIRLON.BO's ROE of +0.84%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to NIRLON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check NIRLON.BO's competition here
KOLTEPATIL.NS vs PURVA.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, PURVA.BO has a market cap of 52.5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while PURVA.BO trades at ₹221.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas PURVA.BO's P/E ratio is 82.30. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to PURVA.BO's ROE of +0.04%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to PURVA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check PURVA.BO's competition here
KOLTEPATIL.NS vs PURVA.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, PURVA.NS has a market cap of 52.4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while PURVA.NS trades at ₹220.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas PURVA.NS's P/E ratio is 82.10. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to PURVA.NS's ROE of +0.04%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to PURVA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check PURVA.NS's competition here
KOLTEPATIL.NS vs RUSTOMJEE.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, RUSTOMJEE.BO has a market cap of 50.3B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while RUSTOMJEE.BO trades at ₹398.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas RUSTOMJEE.BO's P/E ratio is 64.22. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to RUSTOMJEE.BO's ROE of +0.03%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to RUSTOMJEE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check RUSTOMJEE.BO's competition here
KOLTEPATIL.NS vs RUSTOMJEE.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, RUSTOMJEE.NS has a market cap of 50.1B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while RUSTOMJEE.NS trades at ₹397.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas RUSTOMJEE.NS's P/E ratio is 64.06. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to RUSTOMJEE.NS's ROE of +0.03%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to RUSTOMJEE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check RUSTOMJEE.NS's competition here
KOLTEPATIL.NS vs GANESHHOUC.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, GANESHHOUC.NS has a market cap of 48.8B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while GANESHHOUC.NS trades at ₹584.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas GANESHHOUC.NS's P/E ratio is 8.44. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to GANESHHOUC.NS's ROE of +0.22%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to GANESHHOUC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check GANESHHOUC.NS's competition here
KOLTEPATIL.NS vs AGIIL.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, AGIIL.NS has a market cap of 45.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while AGIIL.NS trades at ₹365.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas AGIIL.NS's P/E ratio is 53.28. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to AGIIL.NS's ROE of +0.26%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to AGIIL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check AGIIL.NS's competition here
KOLTEPATIL.NS vs IBULLSLTD.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, IBULLSLTD.NS has a market cap of 44.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while IBULLSLTD.NS trades at ₹20.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas IBULLSLTD.NS's P/E ratio is 15.94. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to IBULLSLTD.NS's ROE of +0.21%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to IBULLSLTD.NS. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check IBULLSLTD.NS's competition here
KOLTEPATIL.NS vs IBULLSLTD.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, IBULLSLTD.BO has a market cap of 44.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while IBULLSLTD.BO trades at ₹19.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas IBULLSLTD.BO's P/E ratio is 15.87. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to IBULLSLTD.BO's ROE of +0.21%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to IBULLSLTD.BO. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check IBULLSLTD.BO's competition here
KOLTEPATIL.NS vs SUNTECK.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SUNTECK.BO has a market cap of 44.1B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SUNTECK.BO trades at ₹300.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SUNTECK.BO's P/E ratio is 21.53. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SUNTECK.BO's ROE of +0.06%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to SUNTECK.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SUNTECK.BO's competition here
KOLTEPATIL.NS vs SUNTECK.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SUNTECK.NS has a market cap of 44.1B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SUNTECK.NS trades at ₹300.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SUNTECK.NS's P/E ratio is 21.54. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SUNTECK.NS's ROE of +0.06%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to SUNTECK.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SUNTECK.NS's competition here
KOLTEPATIL.NS vs TARC.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, TARC.BO has a market cap of 38.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while TARC.BO trades at ₹130.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas TARC.BO's P/E ratio is -44.14. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to TARC.BO's ROE of -0.08%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to TARC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check TARC.BO's competition here
KOLTEPATIL.NS vs TARC.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, TARC.NS has a market cap of 38.5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while TARC.NS trades at ₹130.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas TARC.NS's P/E ratio is -44.05. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to TARC.NS's ROE of -0.08%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to TARC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check TARC.NS's competition here
KOLTEPATIL.NS vs ASHIANA.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ASHIANA.BO has a market cap of 38.1B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ASHIANA.BO trades at ₹378.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ASHIANA.BO's P/E ratio is 31.90. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ASHIANA.BO's ROE of +0.15%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to ASHIANA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ASHIANA.BO's competition here
KOLTEPATIL.NS vs ASHIANA.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ASHIANA.NS has a market cap of 38B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ASHIANA.NS trades at ₹377.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ASHIANA.NS's P/E ratio is 31.81. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ASHIANA.NS's ROE of +0.15%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to ASHIANA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ASHIANA.NS's competition here
KOLTEPATIL.NS vs KESAR.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, KESAR.BO has a market cap of 35.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while KESAR.BO trades at ₹1,255.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas KESAR.BO's P/E ratio is 125.69. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to KESAR.BO's ROE of +0.28%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to KESAR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check KESAR.BO's competition here
KOLTEPATIL.NS vs KOLTEPATIL.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, KOLTEPATIL.BO has a market cap of 33.5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while KOLTEPATIL.BO trades at ₹377.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas KOLTEPATIL.BO's P/E ratio is 64.34. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to KOLTEPATIL.BO's ROE of -0.04%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to KOLTEPATIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check KOLTEPATIL.BO's competition here
KOLTEPATIL.NS vs MARATHON.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, MARATHON.NS has a market cap of 33.1B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while MARATHON.NS trades at ₹490.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas MARATHON.NS's P/E ratio is 13.46. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to MARATHON.NS's ROE of +0.15%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to MARATHON.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check MARATHON.NS's competition here
KOLTEPATIL.NS vs MARATHON.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, MARATHON.BO has a market cap of 32.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while MARATHON.BO trades at ₹488.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas MARATHON.BO's P/E ratio is 13.38. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to MARATHON.BO's ROE of +0.15%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to MARATHON.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check MARATHON.BO's competition here
KOLTEPATIL.NS vs HUBTOWN.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, HUBTOWN.BO has a market cap of 29.4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while HUBTOWN.BO trades at ₹206.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas HUBTOWN.BO's P/E ratio is 19.47. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to HUBTOWN.BO's ROE of +0.06%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to HUBTOWN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check HUBTOWN.BO's competition here
KOLTEPATIL.NS vs HUBTOWN.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, HUBTOWN.NS has a market cap of 29.3B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while HUBTOWN.NS trades at ₹205.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas HUBTOWN.NS's P/E ratio is 19.41. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to HUBTOWN.NS's ROE of +0.06%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to HUBTOWN.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check HUBTOWN.NS's competition here
KOLTEPATIL.NS vs ARVSMART.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ARVSMART.NS has a market cap of 27.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ARVSMART.NS trades at ₹608.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ARVSMART.NS's P/E ratio is 38.25. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ARVSMART.NS's ROE of +0.15%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to ARVSMART.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ARVSMART.NS's competition here
KOLTEPATIL.NS vs ARVSMART.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ARVSMART.BO has a market cap of 27.8B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ARVSMART.BO trades at ₹606.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ARVSMART.BO's P/E ratio is 38.10. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ARVSMART.BO's ROE of +0.15%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to ARVSMART.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ARVSMART.BO's competition here
KOLTEPATIL.NS vs NATIONSTD.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, NATIONSTD.BO has a market cap of 25B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while NATIONSTD.BO trades at ₹1,249.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas NATIONSTD.BO's P/E ratio is 255.94. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to NATIONSTD.BO's ROE of +0.03%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to NATIONSTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check NATIONSTD.BO's competition here
KOLTEPATIL.NS vs AJMERA.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, AJMERA.NS has a market cap of 23.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while AJMERA.NS trades at ₹121.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas AJMERA.NS's P/E ratio is 18.26. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to AJMERA.NS's ROE of +0.12%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to AJMERA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check AJMERA.NS's competition here
KOLTEPATIL.NS vs AJMERA.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, AJMERA.BO has a market cap of 23.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while AJMERA.BO trades at ₹121.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas AJMERA.BO's P/E ratio is 18.23. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to AJMERA.BO's ROE of +0.12%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to AJMERA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check AJMERA.BO's competition here
KOLTEPATIL.NS vs ARKADE.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ARKADE.NS has a market cap of 22.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ARKADE.NS trades at ₹123.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ARKADE.NS's P/E ratio is 15.56. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ARKADE.NS's ROE of +0.16%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to ARKADE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ARKADE.NS's competition here
KOLTEPATIL.NS vs ALEMBICLTD.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ALEMBICLTD.BO has a market cap of 22.4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ALEMBICLTD.BO trades at ₹87.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ALEMBICLTD.BO's P/E ratio is 6.91. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ALEMBICLTD.BO's ROE of +0.13%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to ALEMBICLTD.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ALEMBICLTD.BO's competition here
KOLTEPATIL.NS vs ALEMBICLTD.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ALEMBICLTD.NS has a market cap of 22.4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ALEMBICLTD.NS trades at ₹87.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ALEMBICLTD.NS's P/E ratio is 7.05. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ALEMBICLTD.NS's ROE of +0.13%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to ALEMBICLTD.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ALEMBICLTD.NS's competition here
KOLTEPATIL.NS vs MIIL.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, MIIL.BO has a market cap of 17.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while MIIL.BO trades at ₹794.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas MIIL.BO's P/E ratio is 2089.61. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to MIIL.BO's ROE of +0.41%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to MIIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check MIIL.BO's competition here
KOLTEPATIL.NS vs SHRIRAMPPS.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SHRIRAMPPS.NS has a market cap of 15.5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SHRIRAMPPS.NS trades at ₹90.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SHRIRAMPPS.NS's P/E ratio is 22.10. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SHRIRAMPPS.NS's ROE of +0.07%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to SHRIRAMPPS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SHRIRAMPPS.NS's competition here
KOLTEPATIL.NS vs SHRIRAMPPS.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SHRIRAMPPS.BO has a market cap of 15.5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SHRIRAMPPS.BO trades at ₹90.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SHRIRAMPPS.BO's P/E ratio is 22.10. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SHRIRAMPPS.BO's ROE of +0.07%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to SHRIRAMPPS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SHRIRAMPPS.BO's competition here
KOLTEPATIL.NS vs OMAXE.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, OMAXE.BO has a market cap of 14.3B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while OMAXE.BO trades at ₹78.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas OMAXE.BO's P/E ratio is -2.05. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to OMAXE.BO's ROE of +1.50%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to OMAXE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check OMAXE.BO's competition here
KOLTEPATIL.NS vs OMAXE.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, OMAXE.NS has a market cap of 14.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while OMAXE.NS trades at ₹77.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas OMAXE.NS's P/E ratio is -2.04. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to OMAXE.NS's ROE of +1.50%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to OMAXE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check OMAXE.NS's competition here
KOLTEPATIL.NS vs ASL.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ASL.BO has a market cap of 12.8B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ASL.BO trades at ₹310.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ASL.BO's P/E ratio is -1320.85. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ASL.BO's ROE of +0.11%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to ASL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ASL.BO's competition here
KOLTEPATIL.NS vs ARIHANTSUP.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ARIHANTSUP.BO has a market cap of 11.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ARIHANTSUP.BO trades at ₹260.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ARIHANTSUP.BO's P/E ratio is 24.39. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ARIHANTSUP.BO's ROE of +0.11%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to ARIHANTSUP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ARIHANTSUP.BO's competition here
KOLTEPATIL.NS vs ARIHANTSUP.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ARIHANTSUP.NS has a market cap of 11.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ARIHANTSUP.NS trades at ₹258.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ARIHANTSUP.NS's P/E ratio is 24.31. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ARIHANTSUP.NS's ROE of +0.08%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to ARIHANTSUP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ARIHANTSUP.NS's competition here
KOLTEPATIL.NS vs SURAJEST.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SURAJEST.NS has a market cap of 10.7B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SURAJEST.NS trades at ₹223.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SURAJEST.NS's P/E ratio is 11.72. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SURAJEST.NS's ROE of +0.12%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to SURAJEST.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SURAJEST.NS's competition here
KOLTEPATIL.NS vs MCCHRLS-B.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, MCCHRLS-B.BO has a market cap of 9.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while MCCHRLS-B.BO trades at ₹703.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas MCCHRLS-B.BO's P/E ratio is -7.93. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to MCCHRLS-B.BO's ROE of -1.79%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to MCCHRLS-B.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check MCCHRLS-B.BO's competition here
KOLTEPATIL.NS vs RDBRIL.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, RDBRIL.BO has a market cap of 9.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while RDBRIL.BO trades at ₹53.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas RDBRIL.BO's P/E ratio is 213.12. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to RDBRIL.BO's ROE of +0.03%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to RDBRIL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check RDBRIL.BO's competition here
KOLTEPATIL.NS vs AGIIL.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, AGIIL.BO has a market cap of 8.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while AGIIL.BO trades at ₹364.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas AGIIL.BO's P/E ratio is 47.03. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to AGIIL.BO's ROE of +0.27%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to AGIIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check AGIIL.BO's competition here
KOLTEPATIL.NS vs ARIHANT.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ARIHANT.BO has a market cap of 8.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ARIHANT.BO trades at ₹894.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ARIHANT.BO's P/E ratio is 13.89. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ARIHANT.BO's ROE of +0.23%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to ARIHANT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ARIHANT.BO's competition here
KOLTEPATIL.NS vs ARIHANT.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, ARIHANT.NS has a market cap of 7.7B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while ARIHANT.NS trades at ₹893.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas ARIHANT.NS's P/E ratio is 13.85. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to ARIHANT.NS's ROE of +0.23%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to ARIHANT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check ARIHANT.NS's competition here
KOLTEPATIL.NS vs GEECEE.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, GEECEE.NS has a market cap of 6.7B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while GEECEE.NS trades at ₹322.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas GEECEE.NS's P/E ratio is 16.05. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to GEECEE.NS's ROE of +0.05%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to GEECEE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check GEECEE.NS's competition here
KOLTEPATIL.NS vs GEECEE.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, GEECEE.BO has a market cap of 6.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while GEECEE.BO trades at ₹317.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas GEECEE.BO's P/E ratio is 15.79. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to GEECEE.BO's ROE of +0.05%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to GEECEE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check GEECEE.BO's competition here
KOLTEPATIL.NS vs MODIS.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, MODIS.BO has a market cap of 6.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while MODIS.BO trades at ₹338.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas MODIS.BO's P/E ratio is 26.66. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to MODIS.BO's ROE of +0.28%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to MODIS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check MODIS.BO's competition here
KOLTEPATIL.NS vs HAZOOR.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, HAZOOR.BO has a market cap of 6.5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while HAZOOR.BO trades at ₹27.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas HAZOOR.BO's P/E ratio is 30.11. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to HAZOOR.BO's ROE of +0.06%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to HAZOOR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check HAZOOR.BO's competition here
KOLTEPATIL.NS vs OSWALAGRO.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, OSWALAGRO.BO has a market cap of 6.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while OSWALAGRO.BO trades at ₹45.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas OSWALAGRO.BO's P/E ratio is 7.09. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to OSWALAGRO.BO's ROE of +0.09%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to OSWALAGRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check OSWALAGRO.BO's competition here
KOLTEPATIL.NS vs OSWALAGRO.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, OSWALAGRO.NS has a market cap of 6.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while OSWALAGRO.NS trades at ₹45.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas OSWALAGRO.NS's P/E ratio is 7.08. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to OSWALAGRO.NS's ROE of +0.09%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to OSWALAGRO.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check OSWALAGRO.NS's competition here
KOLTEPATIL.NS vs PENINLAND.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, PENINLAND.BO has a market cap of 5.8B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while PENINLAND.BO trades at ₹17.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas PENINLAND.BO's P/E ratio is -8.94. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to PENINLAND.BO's ROE of -0.28%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to PENINLAND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check PENINLAND.BO's competition here
KOLTEPATIL.NS vs PENINLAND.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, PENINLAND.NS has a market cap of 5.7B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while PENINLAND.NS trades at ₹17.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas PENINLAND.NS's P/E ratio is -8.84. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to PENINLAND.NS's ROE of -0.28%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to PENINLAND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check PENINLAND.NS's competition here
KOLTEPATIL.NS vs PANSARI.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, PANSARI.NS has a market cap of 5.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while PANSARI.NS trades at ₹296.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas PANSARI.NS's P/E ratio is 30.37. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to PANSARI.NS's ROE of +0.11%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to PANSARI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check PANSARI.NS's competition here
KOLTEPATIL.NS vs NILASPACES.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, NILASPACES.BO has a market cap of 5.1B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while NILASPACES.BO trades at ₹12.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas NILASPACES.BO's P/E ratio is 17.60. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to NILASPACES.BO's ROE of +0.19%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to NILASPACES.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check NILASPACES.BO's competition here
KOLTEPATIL.NS vs NILASPACES.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, NILASPACES.NS has a market cap of 5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while NILASPACES.NS trades at ₹12.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas NILASPACES.NS's P/E ratio is 17.51. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to NILASPACES.NS's ROE of +0.19%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to NILASPACES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check NILASPACES.NS's competition here
KOLTEPATIL.NS vs YOGI.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, YOGI.BO has a market cap of 4.7B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while YOGI.BO trades at ₹174.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas YOGI.BO's P/E ratio is 37.83. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to YOGI.BO's ROE of +0.17%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to YOGI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check YOGI.BO's competition here
KOLTEPATIL.NS vs SBGLP.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SBGLP.BO has a market cap of 4.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SBGLP.BO trades at ₹26.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SBGLP.BO's P/E ratio is 14.88. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SBGLP.BO's ROE of +0.44%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to SBGLP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SBGLP.BO's competition here
KOLTEPATIL.NS vs SBGLP.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SBGLP.NS has a market cap of 4.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SBGLP.NS trades at ₹26.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SBGLP.NS's P/E ratio is 14.84. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SBGLP.NS's ROE of +0.44%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to SBGLP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SBGLP.NS's competition here
KOLTEPATIL.NS vs RATNABHUMI.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, RATNABHUMI.BO has a market cap of 4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while RATNABHUMI.BO trades at ₹289.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas RATNABHUMI.BO's P/E ratio is 76.08. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to RATNABHUMI.BO's ROE of +0.07%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to RATNABHUMI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check RATNABHUMI.BO's competition here
KOLTEPATIL.NS vs EMAMIREAL.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, EMAMIREAL.NS has a market cap of 3.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while EMAMIREAL.NS trades at ₹89.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas EMAMIREAL.NS's P/E ratio is -1.81. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to EMAMIREAL.NS's ROE of +1.53%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to EMAMIREAL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check EMAMIREAL.NS's competition here
KOLTEPATIL.NS vs EMAMIREAL.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, EMAMIREAL.BO has a market cap of 3.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while EMAMIREAL.BO trades at ₹88.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas EMAMIREAL.BO's P/E ratio is -1.74. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to EMAMIREAL.BO's ROE of +1.53%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to EMAMIREAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check EMAMIREAL.BO's competition here
KOLTEPATIL.NS vs NILAINFRA.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, NILAINFRA.BO has a market cap of 3.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while NILAINFRA.BO trades at ₹8.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas NILAINFRA.BO's P/E ratio is 13.76. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to NILAINFRA.BO's ROE of +0.13%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to NILAINFRA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check NILAINFRA.BO's competition here
KOLTEPATIL.NS vs NILAINFRA.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, NILAINFRA.NS has a market cap of 3.2B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while NILAINFRA.NS trades at ₹8.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas NILAINFRA.NS's P/E ratio is 13.73. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to NILAINFRA.NS's ROE of +0.13%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to NILAINFRA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check NILAINFRA.NS's competition here
KOLTEPATIL.NS vs MERCANTILE.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, MERCANTILE.BO has a market cap of 2.9B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while MERCANTILE.BO trades at ₹26.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas MERCANTILE.BO's P/E ratio is 23.56. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to MERCANTILE.BO's ROE of +0.04%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to MERCANTILE.BO. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check MERCANTILE.BO's competition here
KOLTEPATIL.NS vs TULIVE.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, TULIVE.BO has a market cap of 2.6B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while TULIVE.BO trades at ₹1,225.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas TULIVE.BO's P/E ratio is -251.02. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to TULIVE.BO's ROE of -0.05%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to TULIVE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check TULIVE.BO's competition here
KOLTEPATIL.NS vs SVGLOBAL.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, SVGLOBAL.BO has a market cap of 2.5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while SVGLOBAL.BO trades at ₹139.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas SVGLOBAL.BO's P/E ratio is 43.46. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to SVGLOBAL.BO's ROE of -0.14%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to SVGLOBAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check SVGLOBAL.BO's competition here
KOLTEPATIL.NS vs KBCGLOBAL.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, KBCGLOBAL.BO has a market cap of 2.5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while KBCGLOBAL.BO trades at ₹0.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas KBCGLOBAL.BO's P/E ratio is -8.00. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to KBCGLOBAL.BO's ROE of -0.03%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to KBCGLOBAL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check KBCGLOBAL.BO's competition here
KOLTEPATIL.NS vs KBCGLOBAL.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, KBCGLOBAL.NS has a market cap of 2.5B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while KBCGLOBAL.NS trades at ₹0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas KBCGLOBAL.NS's P/E ratio is -9.40. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to KBCGLOBAL.NS's ROE of -0.03%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to KBCGLOBAL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check KBCGLOBAL.NS's competition here
KOLTEPATIL.NS vs RVHL.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, RVHL.NS has a market cap of 2.4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while RVHL.NS trades at ₹39.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas RVHL.NS's P/E ratio is 4.71. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to RVHL.NS's ROE of +0.20%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to RVHL.NS. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check RVHL.NS's competition here
KOLTEPATIL.NS vs VGIL.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, VGIL.BO has a market cap of 2.4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while VGIL.BO trades at ₹145.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas VGIL.BO's P/E ratio is 173.51. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to VGIL.BO's ROE of +0.04%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to VGIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check VGIL.BO's competition here
KOLTEPATIL.NS vs RVHL.BO Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, RVHL.BO has a market cap of 2.4B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while RVHL.BO trades at ₹38.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas RVHL.BO's P/E ratio is 4.62. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to RVHL.BO's ROE of +0.20%. Regarding short-term risk, KOLTEPATIL.NS is less volatile compared to RVHL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check RVHL.BO's competition here
KOLTEPATIL.NS vs YAARI.NS Comparison May 2026
KOLTEPATIL.NS plays a significant role within the Real Estate sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, KOLTEPATIL.NS stands at 33.4B. In comparison, YAARI.NS has a market cap of 2.3B. Regarding current trading prices, KOLTEPATIL.NS is priced at ₹377.10, while YAARI.NS trades at ₹21.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
KOLTEPATIL.NS currently has a P/E ratio of 64.35, whereas YAARI.NS's P/E ratio is -3.23. In terms of profitability, KOLTEPATIL.NS's ROE is -0.04%, compared to YAARI.NS's ROE of -0.12%. Regarding short-term risk, KOLTEPATIL.NS is more volatile compared to YAARI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for KOLTEPATIL.NS.Check YAARI.NS's competition here